Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Request for Nominations-12 comments submitted so far--4 available for public to view

View All (4)

No comments posted.

	NOMINATION:COMPOUNDED HORMONE PELLETS a.k.a. BHRT Fused Pellets Implants (SottoPelle; Armor Vie; other brand names)BACKGROUND:I am a board-certified...”
	View Comment Submitter Name: Posted: 02/06/2014 ID: FDA-2013-N-1523-0003

	NOMINATION:Compounded Oral Itraconazole (Sporanox)WHY IS THIS DRUG BEING NOMINATED:Gigi Davidson, RPh, explains it better than I can, but simply put, ORAL...”
	View Comment Submitter Name: Posted: 02/06/2014 ID: FDA-2013-N-1523-0004

	NOMINATION:Human Chorionic Gonadotropin (hCG) in any dosage form not injectable (i.e. it is "difficult to compound" hCG in oral, sublingual, intranasal, and...”
	View Comment Submitter Name: Posted: 02/06/2014 ID: FDA-2013-N-1523-0002

	See attached file(s)”
	View Comment Submitter Name: Posted: 02/06/2014 ID: FDA-2013-N-1523-0005